The bill, known as the Emerson Kate Cole Act, amends existing school medication policies under 70 O.S. 2021, Section 1-116.3. It requires school districts to adopt policies that allow for the self-administration of asthma and anaphylaxis medications by students, with necessary authorizations from parents or legal guardians. Key provisions include the requirement for school employees to call 911 if Epinephrine is administered to a student, and to notify the parent or legal guardian if a student experiences a possible allergic reaction. Additionally, the bill mandates annual training for certain teachers and school employees on recognizing anaphylaxis and administering Epinephrine, with specific content and methods outlined.

The bill also updates statutory language and references, including the replacement of "school" with "board of education" in certain contexts, and emphasizes the need for liability waivers and emergency supplies of medication. It establishes that school districts may maintain a minimum of two Epinephrine injectors and inhalers at each school site, while clarifying that there is no obligation for districts to do so. The act is set to take effect on July 1, 2025, and includes a declaration of emergency for immediate implementation.